Cargando…
Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).
The monoclonal antibody A33 recognises a tumour-associated antigen on human colorectal carcinoma, and has undergone preliminary evaluation in the clinic where selective localisation to hepatic metastases has been demonstrated [Welt et al. (1994) J. Clin. Oncol. 12, 1561-1571]. A33 and an A33 tri-fab...
Autores principales: | Antoniw, P., Farnsworth, A. P., Turner, A., Haines, A. M., Mountain, A., Mackintosh, J., Shochat, D., Humm, J., Welt, S., Old, L. J., Yarranton, G. T., King, D. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074671/ https://www.ncbi.nlm.nih.gov/pubmed/8761364 |
Ejemplares similares
-
Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999) -
Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.
por: King, D. J., et al.
Publicado: (1995) -
Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
por: Casey, J. L., et al.
Publicado: (1996) -
Radioimmunotherapy of malignancy using antibody targeted radionuclides.
por: Cobb, L. M., et al.
Publicado: (1986) -
Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
por: Inui, Akimasa, et al.
Publicado: (1996)